Mumbai: Pharma company GlaxoSmithkline Consumer Healthcare today posted a 18.43% growth in net profit at Rs 32.58 crore for the fourth quarter ended 31 December 2008.
The firm had a net profit of Rs27.51 crore in the fourth quarter of the previous fiscal, GlaxoSmithkline said in a filing to the Bombay Stock Exchange.
The total income rose by 17% to Rs343.56 crore during the quarter under review, from Rs294.29 crore in the same period last fiscal.
The board has declared a dividend of Rs5, at the rate of 50%, on shares of face value of Rs10, for the financial year ended December 2008.
For the financial year ended December 2008, the drug firm reported a net profit of Rs188.33 crore, up 16% over the last fiscal. It had a net profit of Rs162.68 crore in FY’07.
The total income during the financial year ended December 2008 rose 20.64% to Rs1,592.30 crore, from Rs1,319.93 crore in the year-ago period.
Shares of GlaxoSmithkline closed at Rs575, up 2.58% on the BSE.